Table 2.

Adverse events experienced by patients while receiving cabozantinib.

Adverse Event	Any Grade N (%)	Grade 3 or 4 N (%)
Fatigue	13 (50)	0 (0)
Anorexia	9 (35)	1 (4)
AST elevation	9 (35)	0 (0)
Diarrhea	8 (31)	1 (4)
Hypertension	7 (27)	1 (4)
Abdominal discomfort	6 (23)	0 (0)
Dyspepsia	6 (23)	0 (0)
ALT elevation	6 (23)	0 (0)
Stomatitis	4 (15)	1 (4)
Weight loss	4 (15)	0 (0)
Rash	4 (15)	0 (0)
Peripheral edema	4 (15)	0 (0)
Constipation	3 (12)	0 (0)
Low Platelets	2 (8)	1 (4)
Dyspnea	2 (8)	0 (0)
Bowel obstruction	1 (4)	1 (4)
Palmar-Plantar erythrodysesthesia	1 (4)	1 (4)
Rectal abscess	1 (4)	1 (4)
Dry Skin	1 (4)	0 (0)
Hair loss	1 (4)	0 (0)
Dysgeusia	1 (4)	0 (0)
Headache	1 (4)	0 (0)
Back Pain	1 (4)	0 (0)
Insomnia	1 (4)	0 (0)
Flatulence	1 (4)	0 (0)
Confusion	1 (4)	0 (0)
Bilirubin elevation	1 (4)	0 (0)
Anemia	1 (4)	0 (0)